ARCHIVES

ASCO Releases Abstracts To 25,000, But Adds Warning On Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 16 | April 19, 2002

Download PDF Visit The Full Archive

Related Articles

CPRU Program Gets Basic Concept Approval

October 2, 1987

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

March 12, 1999

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

FDA Nearly Wrecks NCI Drug Distribution Program, Finally Agrees To New Guidelines

January 30, 1976

ORI Bars Cleveland Researcher From Federal Funding

March 24, 1995